Mannkind (MNKD) Other financing activities (2014 - 2025)

Mannkind (MNKD) reported Other financing activities of $4.9 million for Q4 2025, up 7241.79% quarter-over-quarter from $67000.0 in Q3 2023.

Mannkind (MNKD) Other financing activities (2014 - 2025) Analysis & Trends

Mannkind (MNKD) has 9 years of Other financing activities data on file, last reported at $4.9 million in Q4 2025.

  • Other financing activities for Q4 2025 came in at $4.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $5.0 million (changed N/A YoY), and the FY2025 annual result was $7.3 million, changed N/A from the prior year.
  • Other financing activities rose to $4.9 million in Q4 2025 per MNKD's latest filing, from $67000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $7.3 million in Q1 2021 and troughed at -$4.1 million in Q4 2021.
  • A 3-year average of $1.4 million and a median of $45500.0 in 2023 frame the typical range for Other financing activities.
  • On a YoY basis, Other financing activities climbed as much as 36240.0% in 2021 and fell as far as 2865.33% in 2021.
  • A 3-year view of Other financing activities shows it stood at -$4.1 million in 2021, then jumped by 101.62% to $67000.0 in 2023, then jumped by 7241.79% to $4.9 million in 2025.
  • Business Quant data shows MNKD's Other financing activities at $4.9 million in Q4 2025, $67000.0 in Q3 2023, and $17000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Mannkind 1.13 Bn 995.19 Mn 82.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.92 Mn
Dec 31, 2025 4.92 Mn
Sep 30, 2023 67,000.00
Sep 30, 2023 67,000.00
Jun 30, 2023 17,000.00
Jun 30, 2023 17,000.00
Mar 31, 2023 24,000.00
Mar 31, 2023 24,000.00
Dec 31, 2021 -4.15 Mn
Dec 31, 2021 -4.15 Mn
Mar 31, 2021 7.27 Mn
Mar 31, 2021 7.27 Mn
Dec 31, 2020 150,000.00
Dec 31, 2020 150,000.00
Sep 30, 2020 37,000.00
Sep 30, 2020 37,000.00
Jun 30, 2020 311,000.00
Jun 30, 2020 311,000.00
Mar 31, 2020 20,000.00
Mar 31, 2020 20,000.00